These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2812955

  • 41. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 42. [The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ternovoĭ KS, Gandzha IM, Babynina LIa, Volobueva ZV, Sukharenko NV, Dibrova TN, Selezneva TN, Ermekova VM.
    Vrach Delo; 1990 Apr; (4):48-50. PubMed ID: 2275166
    [Abstract] [Full Text] [Related]

  • 43. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA, Accinni L, Beiser SM, Christian CL, Cinotti GA, Erlanger BF, Hsu KC, Seegal BC.
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [Abstract] [Full Text] [Related]

  • 44. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
    Kiss M, Husz S, Dobozy A.
    Orv Hetil; 1992 May 03; 133(18):1103-4, 1109-10. PubMed ID: 1579350
    [Abstract] [Full Text] [Related]

  • 45. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K, Doi T, Muso E, Yoshida H, Kanatsu K, Hamashima Y.
    Clin Exp Immunol; 1984 Mar 03; 55(3):487-94. PubMed ID: 6608422
    [Abstract] [Full Text] [Related]

  • 46. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D, Falk W, Dorner M, Schölmerich J, Straub RH.
    J Rheumatol; 2003 Feb 03; 30(2):269-75. PubMed ID: 12563679
    [Abstract] [Full Text] [Related]

  • 47. Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus.
    Teodorescu M, Ustiyan V, Russo K, Rubin RL.
    Clin Immunol; 2004 Feb 03; 110(2):145-53. PubMed ID: 15003811
    [Abstract] [Full Text] [Related]

  • 48. Polymorphonuclear leucocyte fluorescence and cryoglobulin phagocytosis in systemic lupus erythematosus.
    Losito A, Lorusso L.
    Clin Exp Immunol; 1979 Mar 03; 35(3):376-9. PubMed ID: 222518
    [Abstract] [Full Text] [Related]

  • 49. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M, Ferrero B, Cavallo R, Naretto C, Gennaro M, Bellizia L, Sena LM, Roccatello D.
    G Ital Nefrol; 2002 Mar 03; 19(6):617-21. PubMed ID: 12508165
    [Abstract] [Full Text] [Related]

  • 50. Systemic lupus erythematosus.
    Barnett EV, Kantor G, Bickel YB, Forsén R, Gonick HC.
    Calif Med; 1969 Dec 03; 111(6):467-81. PubMed ID: 5358981
    [Abstract] [Full Text] [Related]

  • 51. [Anti-platelet antibodies in patients with autoimmune disorders].
    Kurata Y.
    Rinsho Ketsueki; 1993 May 03; 34(5):593-8. PubMed ID: 8315830
    [Abstract] [Full Text] [Related]

  • 52. Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus.
    Wollina U.
    Allerg Immunol (Leipz); 1984 May 03; 30(1):3-13. PubMed ID: 6233860
    [Abstract] [Full Text] [Related]

  • 53. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M, Abdelaziz A, Abbas A, Mahmoud K, Fathy H, El Mongy S, El-Basyuoni S, Ahmed H, McCoy P.
    Nephrol Dial Transplant; 2009 May 03; 24(5):1495-9. PubMed ID: 19039027
    [Abstract] [Full Text] [Related]

  • 54. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C, Bonin H.
    Clin Exp Immunol; 1983 Sep 03; 53(3):529-35. PubMed ID: 6616954
    [Abstract] [Full Text] [Related]

  • 55. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH, Rasmussen JM, Voss A, Junker P, Leslie RG.
    Arthritis Rheum; 1998 Apr 03; 41(4):613-22. PubMed ID: 9550470
    [Abstract] [Full Text] [Related]

  • 56. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus.
    Traustadottir KH, Sigfusson A, Steinsson K, Erlendsson K.
    J Rheumatol; 2002 Nov 03; 29(11):2359-66. PubMed ID: 12415592
    [Abstract] [Full Text] [Related]

  • 57. [Clinical significance of the estimations of complement and immune complexes].
    Yoshida H, Watanabe K.
    Rinsho Byori; 1989 Dec 03; 37(12):1317-23. PubMed ID: 2693771
    [Abstract] [Full Text] [Related]

  • 58. Cryoglobulin studies in systemic lupus erythematosus.
    Sikander F, Salgaonkar DS, Joshi VR.
    J Postgrad Med; 1989 Jul 03; 35(3):139-43. PubMed ID: 2634754
    [Abstract] [Full Text] [Related]

  • 59. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.
    Arthritis Rheum; 2008 May 03; 58(5):1226-36. PubMed ID: 18438838
    [Abstract] [Full Text] [Related]

  • 60. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 03; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.